Brain Scientific (OTCMKTS:BRSF) Gets CE Mark Approval for NeuroCap Device

August 25, 2022

Brain Scientific (OTCMKTS:BRSF), announced on August 24, 2022, about receiving the Conformité Européenne (CE) Mark for the NeuroCap. The CE mark is confirmation of the fact that the company satisfies all European Medical Device Directive requirements to begin commercializing its innovative neurological devices across the European Continent and other CE mark geographies. Trading Data On Wednesday, BRSF stock moved down 3.25% to $0.1161 with more than 44.97K shares, compared to…

Read More >>